Cross-cohort insights into the association of handgrip strength transitions and burdens with cardiovascular disease risk

Hua Lin, Jike Qi, Yue Jiang, Yushan Yan, Hao Zhang, Xin Zhang, Jingjing Sun, Min Sun, Wensu Chen, Chen Wang, Tongda Xü, Tianyue Xu, X. Q. Hao, Ting Wang, Chu Zheng, Ke Wang, Ping ZengmedRxiv 2026 · DOI

TL;DR

Handgrip strength (HGS) is more than just a measure of "old man strength"—it is a dynamic biomarker for heart health. This study demonstrates that the trajectory of your grip strength over time is a significantly better predictor of cardiovascular disease (CVD) than a single baseline measurement, with particularly pronounced risks observed in East Asian populations.

What Problem Does This Paper Address?

Cardiovascular disease remains the leading cause of death globally, making early risk assessment vital. While handgrip strength has long been recognized as a simple, non-invasive proxy for muscle function and general aging, most clinical research treats it as a static "snapshot."

The authors argue that this approach ignores the reality of human biology: strength fluctuates. A single measurement cannot capture the "dynamic burden" of muscle loss or the potential benefits of strength gains over time. Furthermore, most existing HGS research focuses on single populations, leaving a gap in our understanding of how these strength-to-heart-health associations vary across different ethnicities and regions.

Methods

The researchers employed a longitudinal, cross-cohort approach to track how HGS changes over several years. They moved beyond simple baseline measurements by defining two key concepts:

  1. HGS Transitions: Categorizing participants based on how they moved between "Low," "Moderate," and "High" strength groups between their first and second check-ups (e.g., High $\rightarrow$ Low).
  2. HGS Burdens: They developed three continuous indicators to quantify the "dose" of strength exposure:
  3. HGS Slope: The rate of change over time.
  4. Cumulative HGS: The total "area under the curve" of strength over the follow-up period.
  5. Relative Cumulative HGS: The degree of change relative to the participant's starting point.

To test predictive power, they integrated these metrics into SCORE2, a standard clinical algorithm for predicting 10-year CVD risk, using machine learning models including XGBoost, LightGBM, and RandomForest.

Datasets

The study analyzed a massive dataset of 73,555 participants across four major international cohorts:

  • UK Biobank (UKB): Representing White Europeans.
  • Survey of Health, Ageing and Retirement in Europe (SHARE): A broader European aging cohort.
  • China Health and Retirement Longitudinal Study (CHARLS): Representing East Asians.
  • Korean Longitudinal Study of Ageing (KLOSA): Representing East Asians.

Key Insights and Ideas

  • The Trajectory is the Message: A decline in HGS was a much stronger predictor of heart attack or stroke than simply having low HGS to begin with. Conversely, participants who increased their strength during follow-up saw a reduction in CVD risk, suggesting that muscle maintenance is a modifiable risk factor.
  • Ethnic Sensitivity: The association between declining HGS and CVD was significantly more pronounced in East Asian cohorts (CHARLS and KLOSA) than in European ones. The authors hypothesize this may be due to differences in body composition, such as "sarcopenic obesity"—a phenotype where low muscle mass is combined with high visceral fat, which is more common in Asian populations and highly inflammatory.
  • "Free" Predictive Gains: HGS is incredibly cheap and easy to measure. By adding these longitudinal HGS metrics to the standard SCORE2 model (which usually requires blood work and blood pressure), the researchers achieved a substantial boost in accuracy without needing expensive new clinical tests.

Key Results

  • Incident Cases: Over the follow-up period, 4,722 (6.4%) participants developed CVD.
  • Risk of Decline: Shifting from "High" to "Decreased" HGS was associated with a 31.2% elevated risk of CVD compared to those who stayed strong.
  • The Power of Cumulative Strength: For every standard deviation decrease in cumulative HGS, the risk of CVD jumped by 44%.
  • Model Improvement: Incorporating dynamic HGS metrics into risk models increased the Area Under the Curve (AUC)—a measure of predictive accuracy—by up to 7.6% in Europeans and 5.9% in East Asians.

Limitations and Future Work

The authors acknowledge several limitations:

  • Residual Confounding: While they adjusted for many factors, they couldn't fully account for every medication or specific comorbidity that might influence both strength and heart health.
  • Measurement Noise: HGS can be influenced by acute factors like temporary fatigue, minor hand injuries, or even the participant's mood on the day of the test.
  • Definition Heterogeneity: CVD was defined via ICD codes in the UK Biobank but relied on self-reporting in other cohorts, which could introduce bias.

Future Work: The researchers suggest that future studies should investigate the specific biological mechanisms—such as chronic low-grade inflammation or mitochondrial dysfunction—that link muscle loss to vascular injury. They also call for clinical trials to see if strength-training interventions specifically targeted at HGS preservation can directly lower CVD incidence.

Summary updated

Abstract

Abstract Background Previous studies established handgrip strength (HGS) as a potential risk factor for cardiovascular diseases (CVD). However, existing studies focused exclusively on baseline HGS and neglected longitudinal changes in HGS during follow-up. Thus, our aim was to investigate the associations of transitions and dynamic burdens of HGS with incident CVD risk. Methods We analyzed data from the UK Biobank (UKB), the China Health and Retirement Longitudinal Study (CHARLS), the Survey of Health, Ageing and Retirement in Europe (SHARE), and the Korean Longitudinal Study of Ageing (KLOSA). We defined HGS transitions based on HGS at baseline and the first follow-up, and created three indicators to reflect HGS burdens. Cox models were applied to examine the association of HGS transitions and burdens with incident CVD risk. The predictive value of HGS indices was also evaluated. Results A total of 73,555 participants were retained, and 4,722 (6.4%) incident CVD cases were identified during follow-up. Transition analyses revealed that increased HGS during follow-up was associated with reduced CVD risk, whereas decreased HGS was associated with an elevated risk. Per standard deviation decrement in HGS slope, cumulative HGS and relative cumulative HGS led to a 19.8% (95%CI 1.5~41.5%), 44.0% (95%CI 10.8~87.2%) or 26.7% (95%CI 9.4~46.8%) elevated risk of CVD, respectively. These associations were independent of and more pronounced than HGS, with stronger effects observed in East Asian cohorts (CHARLS and KLOSA) compared to European cohorts (UKB and SHARE). Incorporating dynamic HGS metrics enhanced the predictive accuracy, with HGS burdens providing greater gains than HGS. For the optimal models, all HGS indices resulted in an increase of AUC up to 7.6% in Europeans and 5.9% in East Asians. Conclusions HGS burdens outperformed in predicting cardiovascular health compared to single cross-sectional HGS itself, suggesting the clinical utility of longitudinal HGS monitoring in clinical and public health strategies for CVD prevention.
BibTeX
@misc{lin2026cross,
  author = {Hua Lin and Jike Qi and Yue Jiang and Yushan Yan and Hao Zhang and Xin Zhang and Jingjing Sun and Min Sun and Wensu Chen and Chen Wang and Tongda Xü and Tianyue Xu and X. Q. Hao and Ting Wang and Chu Zheng and Ke Wang and Ping Zeng},
  title = {{Cross-cohort insights into the association of handgrip strength transitions and burdens with cardiovascular disease risk}},
  year = {2026},
  doi = {10.64898/2026.03.05.26347756},
  howpublished = {medRxiv},
}
Figure